Artículos del autor

solaci

Mitral Trial: 2-Year Followup

At present, an important group of patients with mitral valve disease are at high surgical risk, especially...

P2Y12 Inhibitor Monotherapy vs Aspirin: Results of a Network Meta-Analysis

Revascularization and antiaggregation guidelines have typically recommended aspirin (AAS) as first choice for secondary prevention of cardiovascular...

Valve-in-Valve Shows Good Evolution after 2 Years

The degeneration of bioprostheses in aortic position occurs at approximately after 10 to 15 years. In this...

Post PCI FFR

Much research has been done on the usefulness of functional testing such as fractional Flow reserve (FFR)...

Severe Mitral Regurgitation and Cardiogenic Shock: Is Edge-to-Edge a Valid Strategy?

At present, cardiogenic shock continues to present high mortality despite the new treatments and ventricular assistance devices...

IVUS Use in Peripheral Vascular Disease: Should this Tool Be Used More Frequently in Peripheral Interventions?

Use of intravascular ultrasound (IVUS) has increased rapidly, and several randomized and observational studies have shown improved...

Miami Valves 2023: 30% Off for SOLACI Members

On February 2-4, 2023, Miami Valves 2023 will be held in Miami, Florida, USA. This is an...

Changes in Decision-Making Based on OCT

The use of intravascular imaging such as intravascular ultrasound or optical coherence tomography (OCT) both for decision...